Access to treatment for multiple sclerosis must be based on science, not hope

CMAJ. Canadian Medical Association Journal

Volumn 182, Issue 11, 2010, Pages 1151-

  Stanbrook, Matthew B ^a   Hébert, Paul C ^a   Flegel, Ken ^a   MacDonald, Noni ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEALTH CARE ACCESS; HOPE; HUMAN; MULTIPLE SCLEROSIS; SCIENCE; TREATMENT PLANNING; CANADA; COMPLICATION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; STANDARDS; VENOUS INSUFFICIENCY;

ANGIOPLASTY, BALLOON; CANADA; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; MULTIPLE SCLEROSIS; VENOUS INSUFFICIENCY;

EID: 77955462670     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.100835     Document Type: Editorial

References (2)

1. Zamboni P, Galeotti R, Menegatti E, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 2009;50:1348-58.
2. Feds urged to fund MS trial. CBC News. 2010 June 1. Available: www.cbc.ca/health /story/2010/06/01/ms-ccsvi-trial-funding.html (accessed 2010 June 14).